Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
Published version of a preprint
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted a systematic review to estimate associations between oral contraceptive use and breast, cervical, colorectal, and endometrial cancer incidence. We searched PubMed, Embase, and Cochrane Database of Systematic Reviews. Study inclusion criteria were women taking oral contraceptives for contraception or ovarian cancer prevention; includes comparison group with no oral contraceptive use; study reports quantitative associations between oral contraceptive exposure and relevant cancers; controlled study or pooled patient-level meta-analyses; sample size for nonrandomized studies ≥100; peer-reviewed, English-language; published from January 1, 2000 forward. Random-effects meta-analyses were conducted by estimating pooled ORs with 95% confidence intervals (CIs). We included 44 breast, 12 cervical, 11 colorectal, and 9 endometrial cancers studies. Breast cancer incidence was slightly but significantly increased in users (OR, 1.08; CI, 1.00–1.17); results show a higher risk associated with more recent use of oral contraceptives. Risk of cervical cancer was increased with duration of oral contraceptive use in women with human papillomavirus infection; heterogeneity prevented meta-analysis. Colorectal cancer (OR, 0.86; CI, 0.79–0.95) and endometrial cancer incidences (OR, 0.57; CI, 0.43–0.77) were significantly reduced by oral contraceptive use. Compared with never use, ever use of oral contraceptives is significantly associated with decreases in colorectal and endometrial cancers and increases in breast cancers. Although elevated breast cancer risk was small, relatively high incidence of breast cancers means that oral contraceptives may contribute to a substantial number of cases. Cancer Epidemiol Biomarkers Prev; 22(11); 1931–43. ©2013 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“COCs have been associated with small increases in breast cancer and cervical cancer risks and decreases in endometrial, ovarian, and colorectal cancer risks in systematic reviews.”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [212]
Citations
Cites
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., Herrero, R., & Franceschi, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08150-3 · Cited by 692
Use of Contraception in the United States, 1982: (605102007-001)
Bachrach, C. A., & Mosher, W. D. (1984) · PsycEXTRA Dataset · doi:10.1037/e605102007-001 · Cited by 689
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631
Cervical cancer and use of hormonal contraceptives: a systematic review
Smith, J. S., Green, J., de Gonzalez, A. B., Appleby, P., Peto, J., Plummer, M., Franceschi, S., & Beral, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12949-2 · Cited by 544
Oral Contraceptives and the Risk of Breast Cancer
Marchbanks, P. A., McDonald, J. A., Wilson, H. G., Folger, S. G., Mandel, M. G., Daling, J. R., Bernstein, L., Malone, K. E., Ursin, G., Strom, B. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013202 · Cited by 532
Owens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. B., Chang, S., & Helfand, M. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.009 · Cited by 513
Oral contraceptives and the risk of breast cancer*
(2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200304000-00031 · Cited by 431
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“…about the risk of malignancy associated with the use of hormonal contraceptives (Smith et al. , 2003; Zucchetto et al. , 2009; Gierisch et al. , 2013; Havrilesky et al. , 2013; Braganza et al. , 2014; Berlanda et al. , 2016; Wentzensen et al. , 2016; Butt et al. , 2018; Michels et al. , 2018).”
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
“Obtaining a thorough medical history and a blood pressure measurement are important before prescribing a COC.244 Proper patient selection is imperative to minimize risks associated with COC use.”
BackgroundInfluentialRisk factors for endometrial cancer: An umbrella review of the literature
Raglan, O., Kalliala, I., Markozannes, G., Cividini, S., Gunter, M. J., Nautiyal, J., Gabra, H., Paraskevaidis, E., Martin‐Hirsch, P., Tsilidis, K. K., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.31961 · Cited by 648
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Moorman, P. G., Havrilesky, L. J., Gierisch, J. M., Coeytaux, R. R., Lowery, W. J., Peragallo Urrutia, R., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9021 · Cited by 303
Self-citation
Metadata
- Authors
- Gierisch, J. M., Coeytaux, R. R., Urrutia, R. P., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., & Myers, E. R.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2013-11-01
- Volume
- 22
- Issue
- 11
- Pages
- 1931-1943
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2102759586
- Cited by
- 372
- References
- 114
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 24 · 2023: 30 · 2022: 33 · 2021: 28 · 2020: 40 · 2019: 36 · 2018: 36 · 2017: 28 · 2016: 22 · 2015: 28 · 2014: 21 · 2013: 5
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- oral contraceptives, breast cancer, cervical cancer, colorectal cancer, endometrial cancer, cancer risk, human papillomavirus, duration of contraceptive use, ovarian cancer prevention, cancer incidence
- MeSH terms
- Breast Neoplasms, Uterine Cervical Neoplasms, Contraceptives, Oral, Female, Humans, Ovarian Neoplasms, Endometrial Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review. https://app.cochat.ai/papers/10.1158/1055-9965.epi-13-0298
- The paper
- Gierisch, J. M., Coeytaux, R. R., Urrutia, R. P., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., & Myers, E. R. (2013). Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-13-0298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.